Has an Incline man really uncovered what we’ve all been searching for? Maybe so, as sales of his anti-aging supplement top $10 million
PATRICK CUMMINGS RENO GAZETTE-JOURNAL
Entrepreneur and Juvenon
Chief Executive Officer
Nathan Hamilton at his
office in Incline Village.
Nathan Hamilton is hoping in 18 months everyone will have heard of his “Fountain of Youth.”
Hamilton, 39, is the chief executive officer of Juvenon, a health supplement that is creating quite a buzz. The Incline Village man teamed with doctors and biochemists and is hoping the patent-protected pill is just what an aging population needs.
Hamilton said the combination of natural micronutrients in Juvenon increases energy, promotes brain-cell function and supports metabolic efficiency.
“This is the wave of the future,” Hamilton said.
The little pill has received press in Reader’s Digest, the Los Angeles Times and Newsweek, and to date, more than 100,000 people have tried it.
The Berkeley and Harvard Business School graduate has worked for a few biotech companies and now focuses his energy on the $10 million-a-year business.
The product is the result of research led by Dr. Bruce Ames, an award-winning scientist.
Ames is considered one of the leading experts on aging. He is a professor of biochemistry and molecular biology and a senior scientist at the Children’s Hospital Oakland Research Institute.
He developed the formula, which is a combination of micronutrients, at the University of California, Berkeley. The main ingredients, alpha lipoic acid and acetyl-L-carnitine, can be found at any health-food store, but the combination Ames and his team developed is patent protected.
Ames’ research showed that mitochondria, the powerhouses of cells, started to be less productive as people aged.
“Your body is a like a car, and as it ages, the more smoke comes out and the less efficient the car is,” Ames said.
He said by creating a product that could reverse the decay in mitochondria, a lot of the symptoms of aging were reversed as well. He said both alpha lipoic acid and acetyl-L-carnitine give mitochondria a boost.
The money from the sale of the product has gone in to clinical trials on animals and humans.
The product has been tested on rats and dogs, both who showed mental and physical improvements.
“The research on rats has been excellent,” said Ames, who has written several papers on the findings. “Rats made fewer errors on tests and had more energy on the combination of compounds.”
The product was successful in a dog trials, and Juvenon now makes a product specifically for man’s best friend, Vigorate Nourishing Dog Treats.
Ames said the product was tried on a group of heart patients, and results showed that blood pressure went down for those on Juvenon. Ames said he is hopeful more tests will prove Juvenon’s effectiveness on people with genetic disorders, Parkinson’s disease, memory loss and diabetes.
He said the company also keeps a database of customers.
“People are very happy with it, but I will feel much better with more clinical trials to make sure we know all of the side effects.”
He said further clinical trials are awaiting FDA approval.
“One of my colleagues said it best,” Ames said. “He said if you were an old rat, all of this research is good news. If you are an old person, you may want to wait and see.”
Hamilton lives in Incline Village with his wife, Courtney, and his three daughters, Caitlin, Carly and Chloe.
“In Incline, you can build a huge organization and live a fantastic life,” said Hamilton, who is just one of many people who live in the area and run multimillion-dollar companies.
“I think what people do is realize what it does and they stay on it like they would a multivitamin,” Hamilton said.
Hamilton said so far the company has reached customers by advertising in magazines geared towards older people, but the company plans to mass market Juvenon on television and through direct marking in the coming months. A bottle of 60 Juvenon, a month’s supply, costs $39.95. Details: blog.juvenon.com.
Copyright (c) Reno Gazette-Journal. All rights reserved. Reproduced with the permission of Gannett Co., Inc. by NewsBank, inc.